: __________________________________ __________________________________________ (full name) __________________________________________ (company) Sales Report Form for the sale of units of foreign collective investment scheme offered in
investment scheme offered in Thailand Name of foreign collective investment scheme (CIS): Type of arrangement: ( ASEAN Collective Investment Scheme for non-retail investors (NRI CIS) ( ASEAN Collective
: __________________________________ __________________________________________ (full name) __________________________________________ (company) Name of foreign collective investment scheme (CIS): Type of arrangement: ASEAN
advanced technologies from overseas can generate high returns for investors on a daily basis and even higher gains if the existing investors successfully solicit others to join the investment scheme
baht 10,474 12,123 12,547 Gross profit margin (%) 20.47% 22.84% 25.49% ratiosConsolidated financial 2019 2018 2017 Financial data and profitability ratios (continuous) Operating expense (including
conditions including the strong appreciation of THB/USD, which strengthened from the average rate of Baht 35.1060/USD in Q1-17 to Baht 31.5422/USD in the same period this year, and the shortage of some items
2018, resolved as follows: 1. That the audited financial statements including the consolidated financial statements of the Company and its subsidiaries for the six-month period ended 30th June 2018, be
/pubdocs/pdf/IOSCOPD323.pdf. A-3 contemplated that a variety of mechanisms could be used, including both market mechanisms and regulation. The following Code of Conduct Fundam 4 These measures are the
last year. Selling and administrative expenses (including research and development – R&D) in Q1’19 went up 16.7% from Q1’18 and keep close to Q4’18 due to the R&D and sales force invested in order to
year and 23.0% in last quarter this year. Selling and administrative expenses (including research and development – R&D) in Q2’19 went up 21.0% from Q2’18 and up 5.8% from Q1’19 due to R&D and sales